Officer Guido Baechler Files Intent to Sell $904K in Shares, Following Recent $730K Sale
summarizeSummary
An officer of Quantum Cyber N.V. has filed to sell a substantial block of shares, adding to recent insider selling and raising concerns amidst the company's business pivot and financial distress.
check_boxKey Events
-
Officer Files Intent to Sell Shares
Officer Guido Baechler filed a Form 144 to sell 240,000 common shares, valued at approximately $904,800. These shares were recently acquired as a stock award on April 22, 2026.
-
Follows Recent Insider Sale
This proposed sale follows a previous sale of 200,000 shares by the same officer on May 18, 2026, which generated gross proceeds of $730,699.
-
Significant Share Disposition
The combined proposed and recent sales by the officer amount to 440,000 shares, representing approximately 3.0% of the company's outstanding shares and over 3.0% of its market capitalization.
-
Context of Business Pivot and Financial Distress
This insider selling occurs as Quantum Cyber N.V. is undergoing a radical business pivot from life sciences to cyber/drones, marked by recent highly dilutive financing, a 'going concern' warning, and Nasdaq non-compliance issues.
auto_awesomeAnalysis
Officer Guido Baechler has filed a Form 144 indicating intent to sell 240,000 shares, valued at approximately $904,800. This follows a recent sale of 200,000 shares for $730,699 on May 18, 2026, by the same officer. The combined sales represent over 3% of the company's outstanding shares and more than 3% of its market capitalization. This significant insider selling activity, especially from an officer who recently received these shares as compensation, adds to the negative sentiment surrounding the company's recent radical business pivot, substantial dilution, and ongoing financial challenges including a "going concern" warning and Nasdaq non-compliance.
At the time of this filing, QUCY was trading at $3.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $52.9M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.